Scorpius Biomanufacturing

About:

Scorpius Biomanufacturing is a CDMO specializing in mammalian, microbial, and cell therapies for biologics development and manufacturing.

Website: https://scorpiusbiologics.com

Description:

Scorpius Biomanufacturing operates as an integrated contract development and manufacturing organization (CDMO) within the biotechnology industry. It specializes in the development and manufacturing of large molecules, offering services across mammalian, microbial, and cell therapies. The company focuses on providing comprehensive biologics solutions, including clinical manufacturing projects for both mammalian and microbial products. Scorpius Biomanufacturing aims to support the biotechnology sector by offering capacity and expertise in the development and manufacturing of biologics and new modalities, catering to the needs of its clients from development through to manufacturing.

Total Funding Amount:

$1.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Antonio, Texas, United States

Founded Date:

2020-01-01

Contact Email:

hr(AT)scorpius-biologics.com

Founders:

Number of Employees:

51-100

Last Funding Date:

2024-03-08

IPO Status:

Public

Industries:

© 2025 bioDAO.ai